Acer Therapeutics Inc.

NASDAQ: ACER · Real-Time Price · USD
0.66
-0.14 (-17.96%)
At close: Nov 20, 2023, 9:59 PM

Acer Therapeutics Revenue

Acer Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending September 30, 2023, Acer Therapeutics generated $371.79K in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
30
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 0 -100.00%
Dec 31, 2021 1.26M +Infinity%
Dec 31, 2020 0 n/a
Dec 31, 2019 0 -100.00%
Dec 31, 2018 432.12K +-275.66%
Dec 31, 2017 -246K -108.47%
Dec 31, 2016 2.9M +13.65%
Dec 31, 2015 2.56M +100.94%
Dec 31, 2014 1.27M +0.39%
Dec 31, 2013 1.27M +Infinity%
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 -100.00%
Dec 31, 2007 46.45K n/a
Dec 31, 2006 46.45K +Infinity%
Dec 31, 2005 0 n/a
Dec 31, 2004 0 -100.00%
Sep 30, 2003 3.92K -75.61%
Sep 30, 2002 16.05K -93.57%
Sep 30, 2001 249.56K -69.43%
Sep 30, 2000 816.24K -71.87%
Sep 30, 1999 2.9M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.